Skip to main navigation Skip to search Skip to main content

Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management

  • Michael G.Z. Ghali
  • , Justin Davanzo
  • , Madeline Leo
  • , Elias Rizk

Research output: Contribution to journal › Review article › peer-review

Abstract

Posterior reversible encephalopathy syndrome (PRES) is well-described in adults, but has been reported with relative rarity in children, usually occurring in the context of chemotherapy for acute leukemia. Pathogenesis involves perturbed cerebral autoregulation leading to vasogenic edema predominantly affecting the parieto-occipital white matter, though involvement of the frontal and temporal lobes, as well as posterior fossa, is also described. We review the literature on the pathophysiology, diagnosis, and management of PRES in pediatric patients.

Original languageEnglish (US)
Pages (from-to)2365-2372
Number of pages8
JournalLeukemia and Lymphoma
Volume60
Issue number10
DOIs
StatePublished - Aug 24 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management'. Together they form a unique fingerprint.

Cite this